Click on headlines below to download research

Rebranding in exosome targeted drug delivery
ReNeuron Group | 02/11/2022

ReNeuron is a UK-based stem cell research company now strategically re-focused on the development of its exosome drug delivery technologies. Recent encouraging…

Differentiating in exosome drug delivery
ReNeuron Group | 07/10/2022

ReNeuron Group, a stem cell-derived exosome technology company, has presented encouraging preclinical data highlighting the enhanced drug delivery capability…

Extension trial to produce data in Q122
ReNeuron Group | 08/10/2021

ReNeuron has announced that the nine-patient Phase IIa (2m cell dose) extension study (halted in June after a presumed eye infection case) has fully restarted…